Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis

By Gillis D.   Yetiv N.   Gdalevich M.   Mimouni D.   Ashkenazi I.   Shpilberg O.   Eldad A.   Shemer J.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3005-3010

Elsevier

Access to resources Recommend Favorite

Preliminary outcomes and cost-benefit analysis of a community hospital emergency department screening and referral program for patients aged 75 or more

By Warburton Rebecca N.  

International Journal of Health Care Quality Assurance, Vol. 18, Iss. 6, 2005-10 ,pp. : 474-484

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

A cost-benefit analysis of BCG revaccination in the Czech Republic

By Pathania V.S.   Trnka L.   Krejbich F.   Dye C.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1926-1935

Elsevier

Access to resources Recommend Favorite

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

By Coudeville L.   Paree F.   Lebrun T.   Sailly J.-c.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 142-151

Elsevier

Access to resources Recommend Favorite

Murine typhus among Arabs and Jews in Israel 1991–2001

By Bishara Jihad   Hershkovitz Dov   Yagupsky Pablo   Lazarovitch Tzippy   Boldur Ida   Kra-Oz Tzippy   Pitlik Silvio  

European Journal of Epidemiology, Vol. 19, Iss. 12, 2004-12 ,pp. : 1123-1126

Springer Publishing Company

Access to resources Recommend Favorite